Drug intelligence / Profile preview

Algita DX

Development stage
Unknown
Lead developer
Labaid Pharmaceuticals
Modality
Small Molecules
Administration
Oral
01

Overview

Algita DX is an oral dietary supplement and over-the-counter (OTC) formulation developed and manufactured by Labaid Pharmaceuticals. It is a combination product containing calcium carbonate derived from an algae source (equivalent to 500 mg of elemental calcium) and vitamin D3 (cholecalciferol, 200-400 IU). The use of algae-sourced calcium distinguishes it from traditional mineral-based calcium supplements. It is indicated for the treatment and prevention of conditions associated with calcium and vitamin D deficiency, including osteoporosis, rickets, osteomalacia, tetany, and hypoparathyroidism. It is also used to meet increased nutritional demands during pregnancy and lactation, or as supportive therapy for patients with kidney disease, pancreatitis, or those taking antiseizure medications.

Brand names
Algita DX
02

Targets

VDR (Vitamin D receptor)

Beyond the preview

Go deeper on Algita DX.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Algita DX.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call